Annual EBITDA
Summary
- Current Value
- As of today, ARWR annual EBITDA is $122.27M, up +120.99% on
- Historical Performance
- ARWR annual EBITDA is up +172.74% over the past 3 years, up +240.20% over the past 5 years
- All-Time High Comparison
- ARWR annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- ARWR annual EBITDA is +120.99% above its 3-year low of -$582.49M reached on
- Sector Comparison
- ARWR annual EBITDA is higher than 85.11% of companies in Healthcare sector
EBITDA Chart
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $122.27M | +121.0% | +172.7% | +240.2% | +1600.8% | |
| Quarterly EBITDA | -$134.89M | -134.8% | -365.4% | -412.3% | -7602.8% | |
| TTM EBITDA | -$196.53M | -101.7% | -40.3% | -76.5% | -2710.4% | |
| Price | $73.18 | +364.9% | +101.8% | +2.5% | +1172.7% | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $829.45M | +10000.0% | +241.0% | +842.6% | +10000.0% | |
| Annual EPS | -$0.01 | +99.8% | +99.3% | +98.5% | +98.8% | |
| $98.35M | +116.4% | +155.1% | +205.6% | +1217.3% | ||
| Annual Net Income | $30.11M | +104.9% | +117.1% | +135.6% | +507.8% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $122.27M | at high | |
| 5Y | $122.27M | at high | |
| All | $122.27M | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$582.49M | +121.0% | |
| 5Y | -$582.49M | +121.0% | |
| All | -$582.49M | +121.0% |
EBITDA History
FAQ
What is the current annual EBITDA of ARWR?
As of today, ARWR annual EBITDA is $122.27M
What is 1-year change in ARWR annual EBITDA?
ARWR annual EBITDA is up +120.99% year-over-year
What is 3-year change in ARWR annual EBITDA?
ARWR annual EBITDA is up +172.74% over the past 3 years
How far is ARWR annual EBITDA from its all-time high?
ARWR annual EBITDA is currently at its all-time high
How does ARWR annual EBITDA rank versus sector peers?
ARWR annual EBITDA is higher than 85.11% of companies in Healthcare sector
When is ARWR next annual earnings release?
As of today, the next annual earnings release for ARWR has not been scheduled
Quarterly EBITDA
Summary
- Current Value
- As of today, ARWR quarterly EBITDA is -$134.89M, down -385.79% on
- Historical Performance
- ARWR quarterly EBITDA is down -134.83% year-over-year, down -365.35% over the past 3 years
- All-Time High Comparison
- ARWR quarterly EBITDA is currently -134.83% below its historical high of $387.29M set on
- 3-Year Low Comparison
- ARWR quarterly EBITDA is +21.28% above its 3-year low of -$171.36M reached on
- Sector Comparison
- ARWR quarterly EBITDA is higher than 1.20% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$134.89M | -385.8% | -134.8% | -365.4% | -412.3% | |
| Annual EBITDA | $122.27M | – | +121.0% | +172.7% | +240.2% | |
| TTM EBITDA | -$196.53M | -160.3% | -101.7% | -40.3% | -76.5% | |
| Price | $73.18 | +14.6% | +364.9% | +101.8% | +2.5% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $73.74M | -72.1% | -86.4% | -49.6% | +124.7% | |
| Quarterly EPS | -$0.93 | -525.6% | -133.8% | -307.1% | -261.0% | |
| -$141.26M | -446.1% | -137.1% | -393.3% | -400.4% | ||
| Quarterly Net Income | -$137.57M | -587.1% | -137.4% | -388.6% | -413.0% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $387.29M | N/A | -134.8% |
| 3Y | $387.29M | -134.8% | |
| 5Y | $387.29M | -134.8% | |
| All | $387.29M | -134.8% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$159.33M | +15.3% | |
| 3Y | -$171.36M | +21.3% | |
| 5Y | -$171.36M | +21.3% | |
| All | -$171.36M | +21.3% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of ARWR?
As of today, ARWR quarterly EBITDA is -$134.89M
What is ARWR quarterly EBITDA most recent change?
ARWR quarterly EBITDA was down -385.79% on March 31, 2026
What is 1-year change in ARWR quarterly EBITDA?
ARWR quarterly EBITDA is down -134.83% year-over-year
How far is ARWR quarterly EBITDA from its all-time high?
ARWR quarterly EBITDA is currently -134.83% below its historical high of $387.29M set on March 31, 2025
How does ARWR quarterly EBITDA rank versus sector peers?
ARWR quarterly EBITDA is higher than 1.20% of companies in Healthcare sector
When is ARWR next earnings release?
The next earnings release for ARWR is on
TTM EBITDA
Summary
- Current Value
- As of today, ARWR TTM EBITDA is -$196.53M, down -160.35% on
- Historical Performance
- ARWR TTM EBITDA is down -101.72% year-over-year, down -40.29% over the past 3 years
- All-Time High Comparison
- ARWR TTM EBITDA is currently -160.35% below its historical high of $325.65M set on
- 3-Year Low Comparison
- ARWR TTM EBITDA is +67.59% above its 3-year low of -$606.38M reached on
- Sector Comparison
- ARWR TTM EBITDA is higher than 7.85% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$196.53M | -160.3% | -101.7% | -40.3% | -76.5% | |
| Annual EBITDA | $122.27M | – | +121.0% | +172.7% | +240.2% | |
| Quarterly EBITDA | -$134.89M | -385.8% | -134.8% | -365.4% | -412.3% | |
| Price | $73.18 | +14.6% | +364.9% | +101.8% | +2.5% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $622.01M | -43.0% | +14.1% | +128.0% | +597.9% | |
| TTM EPS | -$2.15 | -239.7% | -55.9% | -50.5% | -101.4% | |
| -$221.90M | -173.8% | -87.2% | -47.2% | -87.5% | ||
| TTM Net Income | -$271.86M | -216.4% | -75.8% | -78.7% | -148.1% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $325.65M | -160.3% | |
| 3Y | $325.65M | -160.3% | |
| 5Y | $325.65M | -160.3% | |
| All | $325.65M | -160.3% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$196.53M | at low | |
| 3Y | -$606.38M | +67.6% | |
| 5Y | -$606.38M | +67.6% | |
| All | -$606.38M | +67.6% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of ARWR?
As of today, ARWR TTM EBITDA is -$196.53M
What is ARWR TTM EBITDA most recent change?
ARWR TTM EBITDA was down -160.35% on March 31, 2026
What is 1-year change in ARWR TTM EBITDA?
ARWR TTM EBITDA is down -101.72% year-over-year
How far is ARWR TTM EBITDA from its all-time high?
ARWR TTM EBITDA is currently -160.35% below its historical high of $325.65M set on December 31, 2025
How does ARWR TTM EBITDA rank versus sector peers?
ARWR TTM EBITDA is higher than 7.85% of companies in Healthcare sector
When is ARWR next earnings release?
The next earnings release for ARWR is on
EBITDA Formula
Data Sources & References
- ARWR Official Website arrowheadpharma.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/879407/000087940725000029/0000879407-25-000029-index.htm
- ARWR Profile on Yahoo Finance finance.yahoo.com/quote/ARWR
- ARWR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/arwr
